<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2014-06-20" updated="2019-12-02">
  <drugbank-id primary="true">DB09012</drugbank-id>
  <name>Carbazochrome</name>
  <description>Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone [A19747]. In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity of side effects remains inconclusive. It is not FDA-approved but is available as tablets or IM/SC injections in the treatment of hemorrhages in a number of countries.&#13;
&#13;
Carbazochrome has been investigated for use in the treatment of non-surgical acute uncomplicated hemorrhoids in a mixture with [DB13124], and this combination therapy demonstrated efficacy and safe tolerability either at a local or systemic level [A19744].</description>
  <cas-number>69-81-8</cas-number>
  <unii>81F061RQS4</unii>
  <average-mass>236.231</average-mass>
  <monoisotopic-mass>236.090940262</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>experimental</group>
    <group>withdrawn</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A19744</ref-id>
        <pubmed-id>11409185</pubmed-id>
        <citation>Squadrito F, Altavilla D, Oliaro Bosso S: Double-blind, randomized clinical trial of troxerutin-carbazochrome in patients with hemorrhoids. Eur Rev Med Pharmacol Sci. 2000 Jan-Apr;4(1-2):21-4.</citation>
      </article>
      <article>
        <ref-id>A19745</ref-id>
        <pubmed-id>12928765</pubmed-id>
        <citation>Sendo T, Itoh Y, Aki K, Oka M, Oishi R: Carbazochrome sodium sulfonate (AC-17) reverses endothelial barrier dysfunction through inhibition of phosphatidylinositol hydrolysis in cultured porcine endothelial cells. Naunyn Schmiedebergs Arch Pharmacol. 2003 Sep;368(3):175-80. Epub 2003 Aug 20.</citation>
      </article>
      <article>
        <ref-id>A19746</ref-id>
        <pubmed-id>12206859</pubmed-id>
        <citation>Sendo T, Goromaru T, Aki K, Sakai N, Itoh Y, Oishi R: Carbazochrome attenuates pulmonary dysfunction induced by a radiographic contrast medium in rats. Eur J Pharmacol. 2002 Aug 23;450(2):203-8.</citation>
      </article>
      <article>
        <ref-id>A19747</ref-id>
        <pubmed-id>11922398</pubmed-id>
        <citation>Basile M, Gidaro S, Pacella M, Biffignandi PM, Gidaro GS: Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study. Curr Med Res Opin. 2001;17(4):256-61.</citation>
      </article>
    </articles>
    <textbooks>
      <textbook>
        <ref-id>T40</ref-id>
        <isbn>9781634638289 </isbn>
        <citation>Ghareeb H, Karaman R.  (2015). 6. In Commonly Used Drugs: Uses, Side Effects, Bioavailability and Approaches to Improve It (1st ed., pp. 210). Nova Science Pub Inc; UK ed. edition.</citation>
      </textbook>
    </textbooks>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Indicated for capillary and parenchymal hemorrhage (trauma, tonsillectomy, during surgery), intestinal bleeding, and thrombocytopenic purpura.</indication>
  <pharmacodynamics>Carbazochrome is an anti-bleeding agent that increases platelet aggregation and forms a platelet plug by interacting with α-adrenoreceptors on surface of platelets [T40]. It is shown to improve the structure of local capillary vessels in haemorrhage caused by fragility of capillaries. Carbazochrome capillary stabilizer that reverses pulmonary vascular hyperpermeability and decreases arterial PaO2 in experimental models [A19746].  </pharmacodynamics>
  <mechanism-of-action>Carbazochrome interacts with platelet surface α-adrenoreceptors which are Gq-coupled receptors that leads to activation of PLC IP3/DAG pathway and increase in intracellular calcium levels. Elevated calcium ions bind to calmodulin and activates Ca2+/calmodulin-dependent myosin light chain kinase, allowing the myosin crossbridge to bind to the actin filament and polymerisation of globular actin (G-actin) to filamentous actin (F-actin) [A19745]. Subsequent contraction of endothelial cells changes the shape of platelets and promotes the release of factors such as serotonin, ADP, Von Willebrand and platelet activating factor by platelets that induce aggregation and platelet adherence [T40]. Carbazochrome is reported to inhibit vascular hyperpermeability by inhibiting agonist-induced phosphoinositides hydrolysis caused by various vasoactive agents such as tryptase, thrombin and bradykinin [A19745]. </mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring.</description>
    <direct-parent>Indoles and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organoheterocyclic compounds</superclass>
    <class>Indoles and derivatives</class>
    <subclass/>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Cyclic ketones</alternative-parent>
    <alternative-parent>Enamines</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>N-alkylpyrrolidines</alternative-parent>
    <alternative-parent>Organic carbonic acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <alternative-parent>Semicarbazones</alternative-parent>
    <alternative-parent>Trialkylamines</alternative-parent>
    <alternative-parent>Vinylogous amides</alternative-parent>
    <substituent>Alcohol</substituent>
    <substituent>Aliphatic heteropolycyclic compound</substituent>
    <substituent>Amine</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Carbonic acid derivative</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Cyclic ketone</substituent>
    <substituent>Enamine</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Indole or derivatives</substituent>
    <substituent>Ketone</substituent>
    <substituent>N-alkylpyrrolidine</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Pyrrolidine</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Semicarbazide</substituent>
    <substituent>Semicarbazone</substituent>
    <substituent>Tertiary aliphatic amine</substituent>
    <substituent>Tertiary amine</substituent>
    <substituent>Vinylogous amide</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">3-Hydroxy-1-methyl-5,6-inodlindionsemicarbazon</synonym>
    <synonym language="english" coder="">Adchnon</synonym>
    <synonym language="english" coder="">Adedolon</synonym>
    <synonym language="english" coder="">Adrenostan</synonym>
    <synonym language="german" coder="">Carbazochrom</synonym>
    <synonym language="english" coder="inn">Carbazochrome</synonym>
    <synonym language="latin" coder="">Carbazochromum</synonym>
    <synonym language="spanish" coder="">Carbazocromo</synonym>
    <synonym language="english" coder="">EINECS 200-717-0</synonym>
    <synonym language="english" coder="">NSC 73742</synonym>
  </synonyms>
  <products>
    <product>
      <name>Igatan F</name>
      <labeller>OASIS TRADING</labeller>
      <ndc-id/>
      <ndc-product-code>72689-0027</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-11-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Adcar AC</name>
      <company>Nisshin Pharmaceutical</company>
    </international-brand>
    <international-brand>
      <name>Adona</name>
      <company>Tanabe</company>
    </international-brand>
    <international-brand>
      <name>Adonamin</name>
      <company>Towa Yakuhin</company>
    </international-brand>
    <international-brand>
      <name>Adrenochrome</name>
      <company>Quality Pharm</company>
    </international-brand>
    <international-brand>
      <name>Adrenoxil</name>
      <company>Climax,</company>
    </international-brand>
    <international-brand>
      <name>Adrome</name>
      <company>Landson</company>
    </international-brand>
    <international-brand>
      <name>Almetex</name>
      <company>Alkaloid</company>
    </international-brand>
    <international-brand>
      <name>Anaroxyl</name>
      <company>Organon</company>
    </international-brand>
    <international-brand>
      <name>Auzei</name>
      <company>Nichi-Iko Pharmaceutical</company>
    </international-brand>
    <international-brand>
      <name>Carbajust</name>
      <company>Yoshindo</company>
    </international-brand>
    <international-brand>
      <name>Chichina</name>
      <company>Fuso Pharmaceutical</company>
    </international-brand>
    <international-brand>
      <name>Chromazol</name>
      <company>Solas</company>
    </international-brand>
    <international-brand>
      <name>Crome</name>
      <company>Ferron</company>
    </international-brand>
    <international-brand>
      <name>Cromin's</name>
      <company>Infarmasa</company>
    </international-brand>
    <international-brand>
      <name>Di Ka Ning</name>
      <company>Bosen Bio Pharmaceutical</company>
    </international-brand>
    <international-brand>
      <name>Fleboside</name>
      <company>Acarpia-P</company>
    </international-brand>
    <international-brand>
      <name>Fleboton</name>
      <company>Minapharm</company>
    </international-brand>
    <international-brand>
      <name>Ge Dan</name>
      <company>Changfu Jiejing Pharmaceutical</company>
    </international-brand>
    <international-brand>
      <name>Hemosin K</name>
      <company>Hormona</company>
    </international-brand>
    <international-brand>
      <name>Le Ka Ning</name>
      <company>Pude</company>
    </international-brand>
    <international-brand>
      <name>Le Zhi Na</name>
      <company>Tai'an Pharmaceutical Factory</company>
    </international-brand>
    <international-brand>
      <name>Luoye</name>
      <company>Suzhou No.6</company>
    </international-brand>
    <international-brand>
      <name>Na Neng</name>
      <company>Double-Crane</company>
    </international-brand>
    <international-brand>
      <name>Odanon</name>
      <company>Towa Yakuhin</company>
    </international-brand>
    <international-brand>
      <name>Ophthalm K</name>
      <company>Alfresa Pharma</company>
    </international-brand>
    <international-brand>
      <name>Ranobi</name>
      <company>Koa Isei</company>
    </international-brand>
    <international-brand>
      <name>Styptochrome</name>
      <company>Dr. Reddy's</company>
    </international-brand>
    <international-brand>
      <name>Su Bo Te</name>
      <company>Laien Pharmaceutical</company>
    </international-brand>
    <international-brand>
      <name>Tai Si Neng</name>
      <company>Tide Pharmaceutical</company>
    </international-brand>
    <international-brand>
      <name>Toxivenol</name>
      <company>Kleva</company>
    </international-brand>
    <international-brand>
      <name>Velchrome</name>
      <company>Novell Pharmaceutical</company>
    </international-brand>
    <international-brand>
      <name>Xue Yi Ting</name>
      <company>Weifang Pharmaceutical Factory</company>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Igatan F</name>
      <ingredients>alpha-Tocopherol acetate + Ascorbic acid + Carbazochrome</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Biological Factors</category>
      <mesh-id>D001685</mesh-id>
    </category>
    <category>
      <category>Blood and Blood Forming Organs</category>
      <mesh-id/>
    </category>
    <category>
      <category>Coagulants</category>
      <mesh-id>D003029</mesh-id>
    </category>
    <category>
      <category>Hematologic Agents</category>
      <mesh-id>D006401</mesh-id>
    </category>
    <category>
      <category>Hemostatics</category>
      <mesh-id>D006490</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds, Fused-Ring</category>
      <mesh-id>D000072471</mesh-id>
    </category>
    <category>
      <category>Indoles</category>
      <mesh-id>D007211</mesh-id>
    </category>
    <category>
      <category>Pigments, Biological</category>
      <mesh-id>D010860</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="B02BX02">
      <level code="B02BX">Other systemic hemostatics</level>
      <level code="B02B">VITAMIN K AND OTHER HEMOSTATICS</level>
      <level code="B02">ANTIHEMORRHAGICS</level>
      <level code="B">BLOOD AND BLOOD FORMING ORGANS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB09012.pdf?1499185234</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.47</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-1.9</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.91e+00 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-1.2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>{[(5Z)-3-hydroxy-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indol-5-ylidene]amino}urea</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>carbazochrome</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>236.231</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>236.090940262</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CN1CC(O)C2=C\C(=N\NC(N)=O)C(=O)C=C12</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C10H12N4O3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C10H12N4O3/c1-14-4-9(16)5-2-6(12-13-10(11)17)8(15)3-7(5)14/h2-3,9,16H,4H2,1H3,(H3,11,13,17)/b12-6-</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>XSXCZNVKFKNLPR-SDQBBNPISA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>108.02</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>62.16</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>23.09</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>11.64</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>1.98</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>5360410</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>310264970</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D01864</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>4514501</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Carbazochrome</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL2051960</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/international/carbazochrome.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>